Investment Range
~$50M – $1B USD (est.)Estimated — modeled from this fund's AUM or comparable lenders, not confirmed by the fund. Counts for less than a confirmed range in match scoring.
Deal Types
Equity, Mezzanine, Senior, Unitranche
Sectors
Consumer, Financial Services, Healthcare, Manufacturing, Technology, Real Estate, Energy, Media/Telecom, Mining & Resources
Geographies
Europe, North America, Global
AUM
$53B
Headquarters
Los Angeles, CA, United States
Part of a multi-strategy platform
Crescentruns multiple lending verticals with different check sizes and mandates — this page covers one desk. If your deal isn't an exact fit here, the group may still have the right team; an intro request gets routed to the right desk.
Crescent Capital Group is a global alternative asset manager focused on below investment grade debt securities. They manage various strategies including leveraged loans, high yield bonds, and private debt. They have a long history in the private credit market.
Ebbo: Revolving Credit $0.143M (2023-03-31) [TerraNova tape] Centerplate: Unspecified Term Loan $0.716735M (2015-09-30) [TerraNova tape]
This fund is handled through a TerraNova banker engagement — not a self-serve intro fee.
Banker engagement
Contacting Crescent Capital Group through TerraNova is an advisory path — materials, diligence readiness, and process — not a low-fee self-serve intro.
Talk to a Banker →Investment Range
$10M – $500M USD
Investment Range
~$50M – $1.3B USD (est.)
Estimated — awaiting the fund's own figure
Investment Range
$25M – $500M USD
Match your deal against the full lender book — free to search.
Unlock full deal-team contacts
Reveal 5 deal-team contacts at Crescent Capital Group — emails, LinkedIn, titles (permanent on your account).
Email bounces? Forward to deals@agentasllc.com — we re-credit within a business day. Unlock is private; your info is never sold. Sign in first — the unlock stays on your account.
Profile and contact information is compiled from public sources and TerraNova's own research. It is not provided or endorsed by the fund, and accuracy is not guaranteed.